Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Amarin helps Acadia develop ACP-103

Executive Summary

Amarin Corp. PLC's (neurology and pain management therapeutics) subsidiary Amarin Development AB will use its expertise in drug delivery to help small-molecule drug developer Acadia Pharmaceuticals formulate and manufacture its lead drug candidate ACP-103.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing

Related Companies